A dedicated $8.5B venture and private equity platform engineered to identify, incubate, and scale breakthrough technologies that align with Aevum Zenth’s cross-divisional strategy and long-term industrial vision.
Deploying patient, strategic capital across the technology curve while maintaining operational independence and rigorous portfolio governance.
Capital allocation is structured around five thematic pillars that directly accelerate Aevum Zenth’s industrial roadmap.
Foundational LLMs, agentic systems, edge AI chips, and enterprise automation stacks that reduce operational friction across all conglomerate divisions.
Fusion-adjacent research, next-gen battery chemistry, smart grid orchestration, and carbon capture utilization technologies.
CRISPR delivery platforms, AI-driven drug discovery, synthetic biology manufacturing, and regenerative medicine pipelines.
Humanoid workforce automation, micro-fabrication, additive manufacturing at scale, and supply chain resilience software.
Hypersonic propulsion, satellite constellation ops, in-orbit servicing, and low-earth-orbit manufacturing capabilities.
Vertical farming OS, precision nutrient delivery, alternative protein bioreactors, and climate-resilient crop genetics.
A rigorous, multi-stage evaluation framework ensuring strategic alignment, technical viability, and scalable market potential.
Proposals are evaluated against strategic fit, founder background, IP defensibility, and market timing. TRL 3-6 stage technologies are prioritized.
Cross-functional review by divisional engineers, market analysts, and legal counsel. Includes prototype validation and regulatory pathway assessment.
Final allocation requires majority approval from the Genesis Board. Term sheets are issued within 5 business days of approval.
Portfolio companies receive dedicated PM support, divisional pilot programs, talent placement, and follow-on capital access across the $8.5B fund.
Selected companies currently operating within the Genesis Fund ecosystem.
Distributed inference clusters enabling real-time autonomous decision-making for industrial robotics and defense applications.
AI-driven microgrid orchestration platform stabilizing renewable integration across 14 commercial campuses.
Protein folding simulation engine accelerating late-stage oncology trial designs and reducing R&D timelines by 40%.
Low-cost debris mitigation and satellite repositioning using electrodynamic tether technology.
Whether you're building the next breakthrough technology, seeking strategic capital, or exploring LP opportunities, we welcome your submission.